Vai al contenuto principale della pagina

CRO- contract research organization : how drug research is evolving / / Jakob Miera



(Visualizza in formato marc)    (Visualizza in BIBFRAME)

Autore: Miera Jakob Visualizza persona
Titolo: CRO- contract research organization : how drug research is evolving / / Jakob Miera Visualizza cluster
Pubblicazione: Hamburg, Germany : , : Anchor Academic Publishing, , 2014
©2014
Descrizione fisica: 1 online resource (91 p.)
Disciplina: 615.19
Soggetto topico: Pharmaceutical biotechnology - Germany
Biopharmaceutics - Economic aspects
Soggetto genere / forma: Electronic books.
Note generali: Description based upon print version of record.
Nota di bibliografia: Includes bibliographical references.
Nota di contenuto: CRO - Contract Research Organization; Index; List of Figures; List of Tables; List of Abbreviations; Introduction; Methodology; 1. Merger & Acquisitions Fundamentals; 1.1 Definition and History; 1.2 Types and history of Merger & Acquisitions; 1.3 Recent M&A Trends; 2. Contract Research Organization Industry; 2.1 The Drug Development Process; 2.2 Fundamentals of Contract Research Organizations; 2.3 Strategic Analysis of the Drug Development Market; 2.4 Growth Strategies in CRO Industry; 3. Explanatory Approaches and Motives for M&A; 3.1 Strategic Motives; 3.2 Financial Motives
3.3 Managerial Motives4. Success Factors for the Merger & Acquisitions process; 4.1 Merger & Acquisitions Process; 4.2 Potential Success Factors during the M&A process; 5. Case Study: Merger & Acquisitions in the CRO industry; 5.1 Data & Methodology; 5.2 Why M&A occur in the CRO Industry; 5.3 Potential Success Factors for the M&A process in the CRO industry; 5.4 Reasons for success failures for the M&A process in the CRO industry; 5.5 Determinants and evaluation for success after the M&A; 6. Conclusion and Recommendations; Appendix; Bibliography
Sommario/riassunto: This book deals in general with mergers and acquisitions in the CRO industry, and more specifically with reasons for M and A, success factors during the M and A process, and why M and A can fail in the Contract Research Organization industry. The pharmaceutical industry faces increasing obstacles in respect to the development and introduction of new medications. That has to do with stricter requirements for admission and sharper controls by authorities. Today, the research and development of a new drug can easily consume more than 800 million and lasting between 10 and 15 years. Due to these
Titolo autorizzato: CRO- contract research organization  Visualizza cluster
ISBN: 3-95489-698-2
Formato: Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione: Inglese
Record Nr.: 9910464045703321
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui